Compare BLFS & CGBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLFS | CGBD |
|---|---|---|
| Founded | 1987 | 2012 |
| Country | United States | United States |
| Employees | N/A | 2500 |
| Industry | Medical/Dental Instruments | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 923.5M | 759.8M |
| IPO Year | 2013 | N/A |
| Metric | BLFS | CGBD |
|---|---|---|
| Price | $18.59 | $10.98 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 8 |
| Target Price | ★ $32.00 | $12.92 |
| AVG Volume (30 Days) | 494.2K | ★ 689.5K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 14.73% |
| EPS Growth | ★ 77.27 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $96,214,000.00 | N/A |
| Revenue This Year | $19.73 | $3.74 |
| Revenue Next Year | $17.82 | $1.14 |
| P/E Ratio | ★ N/A | $10.36 |
| Revenue Growth | ★ 16.97 | N/A |
| 52 Week Low | $17.86 | $10.64 |
| 52 Week High | $29.57 | $16.59 |
| Indicator | BLFS | CGBD |
|---|---|---|
| Relative Strength Index (RSI) | 37.55 | 43.08 |
| Support Level | $17.86 | $10.64 |
| Resistance Level | $26.77 | $13.06 |
| Average True Range (ATR) | 0.84 | 0.30 |
| MACD | 0.12 | 0.06 |
| Stochastic Oscillator | 25.10 | 45.37 |
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.